Option chain shows key data for Van Lanschot Kempen's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Van Lanschot Kempen.

Van Lanschot Kempen (OTC:VLNVF) Stock, Option Chain

Van Lanschot Kempen NV is an independent wealth management bank operating primarily in the Netherlands. Its key areas of service include private banking, Evi, asset management, and merchant banking, which drive the vast majority of operating income. most of the bank's earning assets are loans and advances, a majority of which are mortgages. The bank seeks to differentiate itself from traditional competitors with its focus on niche markets and brand recognition. Private banking is the bank's largest core segment. Its private banking customers are mostly entrepreneurs, family businesses, business professionals, executives, and high-net-worth individuals. The most notable portion of the bank's corporate lending book is in the real estate industry.

News

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ACLZ

AMVGF

ANLDF

APNHY

APPB

ARNI

ALLEGIANT GOLD LTD by Allegiant Gold Ltd.

AUXXF

BHAT

BICX

BKUCF

BLMN

BRFH

BRGGF

CARB

CDBMF

CDYCF

CGGGF

CGNSF

CGTFF

CHAKANA COPPER CORP by Chakana Copper Corp.

CHKKF

CHMJF

CHANGE FINANCIAL LTD by Change Financial Ltd.

CNGFF

COLDF

CRPJY

CRTSF

CRXPF

CTTAF

DEWM

DMIFF

ECOS

EMESQ

ESBK

ESTA

FCGD

FCREY

FFXDF

FMOCF

FORR

GARWF

GCGMF

GFSZY

GLDFF

GLNNF

HGSH

HIIQ

IDYA

IGPFF

JMHLY

KERN

KMPH

KUKAF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LFCOF

LGF-A

LGF-B

LIBERTY HEALTH SCI ORD by Liberty Health Sciences Inc

LHSIF

MDFZF

MGAFF

MITJF

MJNE

MMLP

MOAEF

MRZLF

MTFB

NAKD

NDMT

NSCO

NVTR

OCANF

OGDCF

OLVRF

OTTW

OWCP

PHGRF

PTNYF

QRTEB

REXN

SAUC

SGTPY

SMIT

SVNLF

SVVC

THCBF

TKXHF

VRNDF

WAFU

WQTEF

WRTBY

Stocks That Hit 52-Week Lows On Monday

Van Lanschot Kempen NV

Canoo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOEV#NASDAQ">GOEV</a>) shares fell some 72% to 37 cents during Tuesday&#8217;s session after the company announced it filed for <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43098271/canoo-files-bankruptcy-stock-falls-nasa-walmart-dod-usps">Chapter 7 bankruptcy</a>.
What To Know: The announcement marks the end of Canoo&#8217;s operations. The filing, submitted on January 17 in the U.S. Bankruptcy Court for the District of Delaware, includes Canoo and its key subsidiaries, such as Canoo Technologies Inc. and Canoo Manufacturing LLC.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43113872/rivian-lucid-shares-are-falling-today-whats-going-on">Rivian, Lucid Shares Are Falling Today: What&#8217;s Going On?</a>
Under Chapter 7, a court-appointed trustee will oversee the liquidation of Canoo's assets to settle its liabilities. This process eliminates the authority of the company's Board of Directors and executive leadership. All claims will be addressed according to bankruptcy laws.
Once considered a <a href="https://www.benzinga.com/news/21/12/24644913/why-canoo-shares-are-climbing-higher-today">promising player</a> in the EV market, Canoo faced mounting financial challenges, including cash flow issues and delays in production. 
The liquidation underscores the difficulties startups face in the competitive electric vehicle industry, as they contend with high costs and intense competition.
Read Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43113169/trumps-ev-rollback-might-shake-up-etfs-winners-losers-and-teslas-unique-role-in-shifting-market">Trump&#8217;s EV Rollback Might Shake-Up ETFs: Winners, Losers And Tesla&#8217;s Unique Role In Shifting Market</a>
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, GOEV has a 52-week high of $102.07 and a 52-week low of $0.32.

GOEV

Why Canoo (GOEV) Stock Fell 72% Tuesday

Craig-Hallum analyst Chase Knickerbocker maintains Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) with a Buy and lowers the price target from $10 to $8.

Price Target

Analyst Ratings

IRWD

Craig-Hallum Maintains Buy on Ironwood Pharmaceuticals, Lowers Price Target to $8

Trial taking place at <a href="https://www.seha.ae/hospital-detail/1">Sheikh Khalifa Medical City</a>, a flagship tertiary hospital in the United Arab Emirates
POC data generated from this study could potentially lead to reimbursed early patient access in certain European countries for crofelemer for MVID
Crofelemer, Jaguar's novel plant-based prescription drug, has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome with intestinal failure (SBS-IF)
SAN FRANCISCO, CA / <a href="https://www.accessnewswire.com/">ACCESS Newswire</a> / January 22, 2025 / <a href="https://pr.report/66fk">Jaguar Health, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) (Jaguar) family companies <a href="https://pr.report/66fm">Napo Pharmaceuticals</a> (Napo) and <a href="https://pr.report/66fn">Napo Therapeutics</a> today announced that the first patient has been dosed in the independent investigator-initiated POC trial of crofelemer, Jaguar's novel plant-based anti-diarrheal prescription drug, for the rare disease indication of MVID in pediatric patients. POC data generated from this study potentially in the first half of 2025 could lead to reimbursed early patient access to crofelemer for this indication in certain European countries.
The trial will also include pediatric patients with SBS-IF. It is being conducted by Dr. Mohamad Miqdady, a recognized leader in pediatric gastroenterology who is the Division Chief of the Pediatric Gastroenterology, Hepatology &amp; Nutrition Division at <a href="https://pr.report/66fo">Sheikh Khalifa Medical City</a> (SKMC), a flagship tertiary hospital in the UAE and the largest teaching medical center in Abu Dhabi.

Biotech

JAGX

Jaguar Health Announces First Patient Dosed In UAE POC Trial For Crofelemer In Pediatric MVID; Potential For Early Access In Europe By H1 2025; Drug Holds Orphan Designation For MVID And SBS-IF By FDA And EMA

First Community (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCCO#NASDAQ">FCCO</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.49 by 12.24 percent. This is a 27.91 percent increase over earnings of $0.43 per share from the same period last year.

Earnings

Earnings Beats

FCCO

First Community Q4 EPS $0.55 Beats $0.49 Estimate

President Donald Trump's repeal of President Joe Biden's executive order targeting 50% electric vehicle (EV) adoption by 2030 sent shares of Blink Charging Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNK#NASDAQ">BLNK</a>) sliding 5.4% to $1.39 Tuesday. The stock is otherwise flat Wednesday pre-market.
The <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43113169/trumps-ev-rollback-might-shake-up-etfs-winners-losers-and-teslas-unique-role-in-shifting-market">policy reversal</a> raises concerns about reduced federal EV subsidies, relaxed emissions standards and limits on state-level emissions waivers, all of which could slow EV adoption in the U.S.
Read Also: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/01/42985694/chargepoint-outpaces-tesla-in-ev-network-market-share-but-jpmorgan-stays-cautious">ChargePoint Outpaces Tesla In EV Network Market Share, But JPMorgan Stays Cautious</a>
What Else: As a key player in EV charging infrastructure, Blink faces significant headwinds if EV sales falter. A reduction in federal tax credits could discourage EV purchases, directly impacting demand for charging networks. 
Lower consumer interest in EVs might also delay infrastructure expansion and revenue growth for companies like Blink.
While some states may counter federal rollbacks with pro-EV initiatives, uncertainty looms over Blink's near-term outlook. Increased volatility for EV-dependent stocks may happen in the near-term but global electrification trends could serve as a potential long-term tailwind.
Read Also: <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">Trump&#8217;s Plan To End $7,500 EV Tax Credits Could Be &#8216;Devastating&#8217; For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk&#8217;s Company</a>
<h2 class="wp-block-heading">Should I Sell My BLNK Stock?</h2>
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
Shares of Blink Charging have lost 45.06% year to date. This compares to the average annual return of -59.26%, meaning the stock has outperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity. 
For analysis tools, charting data and access to exclusive stock news, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
BLNK has a 52-week high of $3.75 and a 52-week low of $1.31.

BLNK

Why Blink Charging (BLNK) Stock Is Volatile

Craig-Hallum analyst George Sutton maintains Agilysys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGYS#NASDAQ">AGYS</a>) with a Buy and lowers the price target from $125 to $120.

AGYS

Craig-Hallum Maintains Buy on Agilysys, Lowers Price Target to $120

Ratings for H.B. Fuller (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $69.5, with a high estimate of $78.00 and a low estimate of $60.00. Experiencing a 9.74% decline, the current average is now lower than the previous average price target of $77.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1737554468_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of H.B. Fuller by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Begleiter</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$72.00</td>
<td>$75.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$68.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$78.00</td>
<td>$85.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to H.B. Fuller. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of H.B. Fuller compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of H.B. Fuller's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into H.B. Fuller's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FUL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on H.B. Fuller analyst ratings.</a>
<h2>Delving into H.B. Fuller's Background</h2>
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives and Construction Adhesives. It generates the maximum revenue from hygiene, health and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based and solvent-based products for applications in various markets, including packaging , converting, nonwoven and hygiene (disposable diapers, feminine care and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
<h3>Key Indicators: H.B. Fuller's Financial Health</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: Over the 3 months period, H.B. Fuller showcased positive performance, achieving a revenue growth rate of 1.92% as of 31 August, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Net Margin: H.B. Fuller's net margin is impressive, surpassing industry averages. With a net margin of 6.03%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): H.B. Fuller's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.05% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): H.B. Fuller's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.12%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a high debt-to-equity ratio of 1.1, H.B. Fuller faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: H.B. Fuller In The Eyes Of 4 Experts

Global energy technology company SLB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) and leading geothermal developer Star Energy Geothermal, a subsidiary of Indonesia's largest renewable energy company Barito Renewables (IDX: BREN), today announced a collaboration agreement to accelerate advanced technologies for geothermal asset development.
The collaboration will combine Star Energy Geothermal's extensive knowledge of geothermal development with SLB's decades of experience developing and industrializing technology solutions for the energy sector. Working closely together, SLB and Star Energy Geothermal aim to deploy technologies that shift the economics of conventional geothermal projects and improve recovery rates of geothermal assets.

SLB And Star Energy Geothermal Announce Technology Collaboration To Accelerate New Commercial Technologies That Address Geothermal Development Challenges

4 analysts have shared their evaluations of STMicroelectronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STM#NYSE">STM</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $33.0, a high estimate of $36.00, and a low estimate of $30.00. Observing a downward trend, the current average is 8.97% lower than the prior average price target of $36.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1737554459_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive STMicroelectronics. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Maintains</td>
<td>Positive</td>
<td>$33.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Christopher Rolland</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$33.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Tristan Gerra</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Anthony Stoss</td>
<td>Craig-Hallum</td>
<td>Lowers</td>
<td>Buy</td>
<td>$36.00</td>
<td>$42.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to STMicroelectronics. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of STMicroelectronics compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for STMicroelectronics's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
For valuable insights into STMicroelectronics's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/STM/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on STMicroelectronics analyst ratings.</a>
<h2>Unveiling the Story Behind STMicroelectronics</h2>
A merger between Italian firm SGS Microelettronica and the nonmilitary business of Thomson Semiconducteurs in France formed STMicroelectronics in 1987. STMicroelectronics is a leader in a variety of semiconductor products, including analog chips, discrete power semiconductors, microcontrollers, and sensors. It is an especially prominent chip supplier to the industrial and automotive industries.
<h3>A Deep Dive into STMicroelectronics's Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: STMicroelectronics's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -26.63%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: STMicroelectronics's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 10.8%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): STMicroelectronics's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.98%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): STMicroelectronics's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.37%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.19, STMicroelectronics adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where STMicroelectronics Stands With Analysts

Alphabet Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google earmarked over $1 billion investment <a target="_blank" href="https://www.benzinga.com/topic/anthropic" rel="noreferrer noopener">into OpenAI rival</a> Anthropic, intensifying its rivalry with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) and Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>).
In 2023, Google <a target="_blank" href="https://www.benzinga.com/government/24/10/41528255/googles-2b-investment-in-anthropic-under-scrutiny-uk-opens-competition-inquiry" rel="noreferrer noopener">committed up to $2 billion</a> to the Microsoft-backed OpenAI rival, Financial Times <a target="_blank" href="https://www.ft.com/content/ed631513-dd37-44a3-a536-b2002f5727cc" rel="noreferrer noopener">reports</a>, citing unnamed sources familiar with the matter. The new tranche of money from Google into Anthropic adds to Amazon&#8217;s total investment of $8 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43110913/apples-iphone-dependence-remains-but-services-wearables-offer-growth-potential-analyst" rel="noreferrer noopener">Apple&#8217;s iPhone Dependence Remains, But Services, Wearables Offer Growth Potential: Analyst</a>
Google invented the technology on which Anthropic&#8217;s Claude and OpenAI&#8217;s GPT4 models are built.
Anthropic was also on the verge of securing a further $2 billion from Silicon Valley venture capital investors in a deal likely to triple the start-up&#8217;s valuation to about $60 billion, Financial Times cites unnamed sources familiar with the deal.
Like Meta and Microsoft, OpenAI and Elon Musk&#8217;s xAI raised over $10 billion in 2024.
According to Financial Times, Anthropic&#8217;s revenue hit an annualized $1 billion in December, up roughly 10 times on a year earlier.
<a target="_blank" href="https://www.benzinga.com/media/24/12/42709007/sam-altmans-openai-plans-major-revamp-corporate-structure" rel="noreferrer noopener">Prior reports indicated</a> that OpenAI, worth $157 billion, will be restructuring its non-profit structure into a public benefit corporation in 2025 as developing large-scale language models requires substantial investments.
In related news, on Tuesday, OpenAI, SoftBank (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>), and Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) introduced a <a target="_blank" href="https://www.benzinga.com/25/01/43111153/nvidia-and-ai-stock-rises-as-trump-announces-500-billion-stargate-ai-infrastructure-venture" rel="noreferrer noopener">$500 billion joint venture</a>, Stargate, to build AI infrastructure in the U.S. Stargate&#8217;s debut project will focus on creating a large-scale data center in Texas, with plans to expand to other states.&nbsp;
Also, in January, Microsoft launched its CoreAI division to streamline AI tools and <a target="_blank" href="https://www.benzinga.com/25/01/42980720/microsoft-taps-meta-veteran-to-lead-new-coreai-division-plans-shift-from-openai-dependence" rel="noreferrer noopener">build AI apps</a>. The company committed $80 billion for AI-driven data centers.
Price Action: GOOGL stock is up 0.38% at $200.39 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43110753/aws-robotics-prime-video-ads-fuel-amazon-growth-potential-analysts" target="_blank" rel="noreferrer noopener">AWS, Robotics, Prime Video Ads Fuel Amazon Growth Potential: Analysts</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Media

AMZN

GOOG

GOOGL

MSFT

ORCL

SFTBF

SFTBY

Anthropic Gains Big With Google Backing, Aims for $60 Billion Valuation and Surging AI Revenue

United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for United Parcel Service, revealing an average target of $149.25, a high estimate of $170.00, and a low estimate of $135.00. This current average reflects an increase of 2.05% from the previous average price target of $146.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1737554446_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of United Parcel Service among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Chappell</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$147.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Ken Hoexter</td>
<td>B of A Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$150.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Brian Ossenbeck</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$135.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Christian Wetherbee</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$150.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Fadi Chamoun</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Ariel Rosa</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$158.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Scott Schneeberger</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$146.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Thomas Wadewitz</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$159.00</td>
</tr>
<tr>
<td>Ken Hoexter</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Brian Ossenbeck</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$139.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>J. Bruce Chan</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$156.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Bascome Majors</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Neutral</td>
<td>$140.00</td>
<td>$135.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to United Parcel Service. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of United Parcel Service compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of United Parcel Service's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of United Parcel Service's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/UPS/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on United Parcel Service analyst ratings.</a>
<h2>Get to Know United Parcel Service Better</h2>
As the world's largest parcel delivery company, UPS manages a massive fleet of more than 500 planes and 100,000 vehicles, along with many hundreds of sorting facilities, to deliver an average of about 22 million packages per day to residences and businesses across the globe. UPS' domestic US package operations generate around 64% of total revenue while international package makes up 20%. Air and ocean freight forwarding and contract logistics make up the remainder.
<h3>United Parcel Service's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: United Parcel Service displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 5.62%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.92%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): United Parcel Service's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 9.08%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): United Parcel Service's ROA excels beyond industry benchmarks, reaching 2.24%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.56.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On United Parcel Service Through 12 Analysts

15 analysts have expressed a variety of opinions on Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">6</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $515.13, a high estimate of $600.00, and a low estimate of $465.00. This current average has increased by 2.66% from the previous average price target of $501.79. 
<img src="https://www.benzinga.com/files/images/story/2025/1737554434_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The analysis of recent analyst actions sheds light on the perception of Microsoft by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$540.00</td>
<td>$548.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Announces</td>
<td>Overweight</td>
<td>$509.00</td>
<td>-</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$520.00</td>
<td>$470.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$550.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$515.00</td>
<td>$475.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$525.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$510.00</td>
<td>$480.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$500.00</td>
<td>$500.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$500.00</td>
<td>$510.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$465.00</td>
<td>$470.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$475.00</td>
<td>$495.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$470.00</td>
<td>$470.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$548.00</td>
<td>$506.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$600.00</td>
<td>$600.00</td>
</tr>
<tr>
<td>Mark Moerdler</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$500.00</td>
<td>$501.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Microsoft. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Microsoft compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Microsoft's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Microsoft's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MSFT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Microsoft analyst ratings.</a>
<h2>Unveiling the Story Behind Microsoft</h2>
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
<h3>Key Indicators: Microsoft's Financial Health</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Microsoft displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 16.04%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: Microsoft's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 37.61%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Microsoft's ROE excels beyond industry benchmarks, reaching 8.87%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Microsoft's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 4.77%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.21, Microsoft adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 15 Analyst Projections For Microsoft

In the last three months, 6 analysts have published ratings on Adtran Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADTN#NASDAQ">ADTN</a>), offering a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $12.0, a high estimate of $15.00, and a low estimate of $10.00. This upward trend is apparent, with the current average reflecting a 36.36% increase from the previous average price target of $8.80.
<img src="https://www.benzinga.com/files/images/story/2025/1737554426_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Adtran Holdings by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$11.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Christian Schwab</td>
<td>Craig-Hallum</td>
<td>Announces</td>
<td>Buy</td>
<td>$15.00</td>
<td>-</td>
</tr>
<tr>
<td>Tim Savageaux</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$10.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$10.00</td>
<td>$6.00</td>
</tr>
<tr>
<td>Ryan Koontz</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$11.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Adtran Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Adtran Holdings compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Adtran Holdings's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Adtran Holdings's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/ADTN/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Adtran Holdings analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Adtran Holdings</h2>
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access &amp; Aggregation, and Optical Networking Solutions; and Services &amp; Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access &amp; Aggregation, and Optical Networking Solutions.
<h3>Adtran Holdings's Financial Performance</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Decline in Revenue: Over the 3 months period, Adtran Holdings faced challenges, resulting in a decline of approximately -16.39% in revenue growth as of 30 September, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -13.72%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Adtran Holdings's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -14.39%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Adtran Holdings's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -2.44%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Adtran Holdings's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.01.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADTN

Assessing Adtran Holdings: Insights From 6 Financial Analysts

5 analysts have shared their evaluations of RadNet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDNT#NASDAQ">RDNT</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $86.6, a high estimate of $100.00, and a low estimate of $74.00. This upward trend is evident, with the current average reflecting a 1.64% increase from the previous average price target of $85.20.
<img src="https://www.benzinga.com/files/images/story/2025/1737554416_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive RadNet. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$74.00</td>
<td>$85.00</td>
</tr>
<tr>
<td>Brian Tanquilut</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$80.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Brian Tanquilut</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$85.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$94.00</td>
<td>$80.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to RadNet. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of RadNet compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of RadNet's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into RadNet's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/RDNT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on RadNet analyst ratings.</a>
<h2>All You Need to Know About RadNet</h2>
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.
<h3>A Deep Dive into RadNet's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining RadNet's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 14.72% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: RadNet's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 0.7%, the company may face hurdles in effective cost management.
Return on Equity (ROE): RadNet's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.36%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): RadNet's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.1%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.94.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

RDNT

Breaking Down RadNet: 5 Analysts Share Their Views

Lockheed Martin (NYSE:&nbsp;LMT) has received a $270 million contract from the U.S. Air Force to integrate a system of next-generation infrared defensive sensors on the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4345890-1&amp;h=3695806631&amp;u=https%3A%2F%2Fwww.lockheedmartin.com%2Fen-us%2Fproducts%2Ff-22.html&amp;a=F-22+Raptor">F-22 Raptor</a>. &nbsp;
The F-22 will soon feature a newly developed, distributed set of embedded TacIRST sensors developed by Lockheed Martin to enhance aircraft survivability and lethality, known as the Infrared Defensive System (IRDS). In addition to managing integration of IRDS on the F-22, the company will also support integration on other platforms.

Contracts

Lockheed Martin Awarded $270M Contract To Modernize Air Force F-22 Raptor With Advanced Infrared Threat-Detection Sensors

Carpenter Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRS#NYSE">CRS</a>) has outperformed the market over the past 15 years by 2.47% on an annualized basis producing an average annual return of 14.58%. Currently, Carpenter Tech has a market capitalization of $10.59 billion. 
Buying $1000 In CRS: If an investor had bought $1000 of CRS stock 15 years ago, it would be worth $7,362.62 today based on a price of $212.50 for CRS at the time of writing.
<h3>Carpenter Tech's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737554410_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) shares soared 15% in premarket trading on Wednesday, hitting $1,000 after the streaming giant reported fourth-quarter earnings that smashed Wall Street expectations on revenue, <a href="https://www.benzinga.com/earnings">profitability, and subscriber growth. </a>
In a note on Wednesday, Goldman Sachs analyst Eric Sheridan raised the 12-month price target on Netflix stock from $850 to $960, citing expansion into live entertainment, the growing success of its ad-supported tier, and strategic price increases.
Yet, the investment bank opted to maintain a Neutral rating, indicating that the stock's recent gains already reflect much of its future growth potential.
<h3 class="wp-block-heading">Earnings Beat, Subscriber Growth Accelerates</h3>
Netflix reported fourth-quarter revenue of $9.88 billion, beating analyst forecasts even as a stronger U.S. dollar created foreign exchange headwinds. Operating income climbed to $2.63 billion, exceeding expectations and underscoring the company's improving profitability.
A key driver of growth has been Netflix's ad-supported tier, which saw a 30% quarter-over-quarter rise in subscribers and accounted for more than 55% of new sign-ups in markets where it is available. The trend signals a strategic shift, with the company focusing less on sheer subscriber numbers and more on revenue diversification.
Netflix also ramped up capital returns, buying back $1 billion in shares in the fourth quarter. Its board approved an additional $15 billion in share repurchases, reinforcing management's confidence in the company's long-term trajectory.
<h3 class="wp-block-heading">Goldman Sachs: Valuation Now a Concern</h3>
Netflix&#8217;s ability to &#8220;sustain double-digit revenue growth with room to expand margins in the coming years,&#8221; led Sheridan to raise his price target on Netflix to $960.
Yet, he stopped short of upgrading the stock, warning that Netflix's rapid price appreciation, up by over 35% since the third quarter&#8217;s earnings report, has made risk-reward less compelling.
Sheridan indicated that while Netflix is executing well, the stock has already surged sharply since its last earnings report, far outpacing the broader market. 
With the latest rally pushing shares to $1,000, Goldman believes much of the company's long-term growth potential is already reflected in the price.
<h3 class="wp-block-heading">What's Next for Netflix?</h3>
The company expects first-quarter 2025 revenue of $10.42 billion, slightly below analyst estimates, and projected free cash flow of about $8 billion for the full year, lower than Goldman's previous estimate of $8.7 billion.
Investors now face a key decision: Is Netflix's stock still an attractive buy after its meteoric rise, or has the rally outpaced its fundamentals? Goldman Sachs appears to lean toward the latter, even as Wall Street cheers the latest earnings win.
Read now: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43122112/us-stocks-likely-to-open-higher-as-president-trump-announces-500-billion-ai-project-oracle-netflix-nvidia-among-stocks-in-focus">US Stocks Likely To Open Higher As President Trump Announces $500 Billion AI Project: Oracle, Netflix, Nvidia Among Top Stocks To Watch</a></li>
</ul>
Photo by Kaspars Grinvalds on Shutterstock.

Analyst Color

NFLX

Netflix Stock Breaks $1,000 Post-Earnings: Goldman Flags Valuation Stretch

Shares of Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) fell sharply by 6.5% to $13.29 Tuesday following President Donald Trump's repeal of a <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43113872/rivian-lucid-shares-are-falling-today-whats-going-on">2021 executive order</a> by former President Joe Biden, which had set a target for 50% of new vehicles sold in the U.S. to be electric by 2030. 
The <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43113169/trumps-ev-rollback-might-shake-up-etfs-winners-losers-and-teslas-unique-role-in-shifting-market">policy shift</a> freezes unspent funds from a $5 billion EV charging infrastructure program and signals a reassessment of emissions regulations requiring automakers to sell up to 56% EVs by 2032 to meet federal standards.
Read Also: <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/01/42985694/chargepoint-outpaces-tesla-in-ev-network-market-share-but-jpmorgan-stays-cautious">ChargePoint Outpaces Tesla In EV Network Market Share, But JPMorgan Stays Cautious</a>
What To Know: Rivian, known for its premium electric trucks, SUVs and delivery vans, is particularly exposed to these changes. The potential repeal of the $7,500 federal tax credit for EV buyers could dampen demand for Rivian&#8217;s vehicles, which already face steep price points compared to traditional gas-powered models. 
The company's growth also relies heavily on expanding EV infrastructure, which could slow as federal funds are redirected.
Furthermore, Trump's challenge to California's zero-emission vehicle mandates—adopted by 11 other states—introduces additional uncertainty for Rivian, whose sales could suffer in markets where emissions rules drive EV adoption.
The sweeping rollback of federal EV policies underscores significant near-term challenges for Rivian and other emerging EV manufacturers reliant on government incentives and infrastructure investment.
Read Also: <a href="https://www.benzinga.com/trading-ideas/25/01/43116755/trumps-plan-to-end-7500-ev-tax-credits-could-be-devastating-for-telsa-rivals-poll-says-could-be-bullish-for-elon-musks-company">Trump&#8217;s Plan To End $7,500 EV Tax Credits Could Be &#8216;Devastating&#8217; For Telsa Rivals, Poll Says Could Be Bullish For Elon Musk&#8217;s Company</a>
Price Action: Rivian stock is lower by 1.3% to $13.12 during Wednesday&#8217;s pre-market session. Investors can gain exposure to RIVN by investing in the iShares Self-Driving EV and Tech ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDRV#NASDAQ">IDRV</a>).
<h2 class="wp-block-heading">How To Buy RIVN Stock</h2>
By now you're likely curious about how to participate in the market for Rivian Automotive &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the case of Rivian Automotive, which is trading at $13.29 as of publishing time, $100 would buy you 7.52 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, RIVN has a 52-week high of $18.86 and a 52-week low of $8.26.

IDRV

RIVN

What's Going On With Rivian (RIVN) Stock?

Craig-Hallum analyst Aaron Spychalla initiates coverage on Daktronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAKT#NASDAQ">DAKT</a>) with a Buy rating and announces Price Target of $26.

Initiation

DAKT

Craig-Hallum Initiates Coverage On Daktronics with Buy Rating, Announces Price Target of $26

Scotiabank analyst Orest Wowkodaw maintains Teck Resources (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TECK#TSX">TECK</a>) with a Sector Outperform and lowers the price target from C$75 to C$73.

TSX:TECK

TSX:TECK/B

Scotiabank Maintains Sector Outperform on Teck Resources, Lowers Price Target to C$73

Van Lanschot Kempen

Comments

Van Lanschot Kempen

Van Lanschot Kempen (VLNVF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga